Lung Condition

High BP affects breathing capacity but physical activity can help: Study

High blood pressure impairs one's breathing capacity by hardening the airways in the respiratory system, thereby increasing resistance, a study has found. However, being physically active can help by improving the functioning of respiratory muscles, resulting in better coordination between ventilation and blood flow in the lungs, researchers from the Federal University of Sao Paulo, Brazil, found. Hypertension, in which one's blood pressure remains unusually high, is known to thicken the blood vessels and harden the arteries. The researchers said that something similar happens with the bronchi -- branches of the main windpipe (trachea) -- in the respiratory system as well. "This is very important as the more hardened the bronchi becomes, the more difficult it becomes for air to enter and leave the lungs. In the long run, this accelerated process of hardening of the bronchi makes breathing difficult for older people. Worse still, it's a cycle: lower oxygen saturation accelerates the

Limit number of vehicles per family to curb air pollution, say experts

Rise in air pollution is linked to growing respiratory ailments in India, experts have said and urged the government to bring a policy limiting the number of cars per family and restricting the number of vehicles plying on roads at a time. On the sidelines of the 25th National Conference on Pulmonary Diseases (NAPCON-2023), organised by the Indian Chest Society here, Dr Rakesh K Chawla, the chairman of Pulmonology and Critical Care at Jaipur Golden Hospital, said air pollution has short-term as well as long-term effects on health. "The immediate effects are in the form of irritation in the eyes and throat. Also, there is an increase in the severity of asthma attacks," said Dr Chawla, who is also the organising chairman of NAPCON-2023. The conference was organised to discuss air pollution and diseases caused by it as well as the advancements in the field of pulmonology. Dr Chawla said the long-term effects of air pollution include respiratory diseases and lung cancer, and the worst

World Lung Cancer Day 2023: Theme, History, Importance, and Quotes

Lung and bronchus cancer, according to the National Cancer Institute, account for the majority of deaths. Lung cancer was prevalent in about 1,03,371 people in 2022

Cleaner air may boost lung capacity of children, adolescents: Study

Cutting down on air pollution can help improve the lung capacity of children and adolescents, finds a study

11% of Covid cases that needed hospitalisations had lung scarring: Study

Up to 11 per cent of Covid cases that needed hospitalisation had lung scarring which may be irreversible and could get worse over time, according to a study conducted in the United States. The study, published in the American Journal of Respiratory and Critical Care Medicine, sought to determine the percentage of COVID-19 patients, with various degrees of severity, discharged from hospital who had a type of fibrotic lung damage, known as interstitial lung disease, that requires follow-up care. Interstitial lung disease refers to a broad group of diseases that are characterized by lung scarring, including idiopathic lung fibrosis. This scarring makes it difficult to breathe and get oxygen into the bloodstream. Lung damage caused by this may be irreversible and get worse over time. "We estimated that up to 11 per cent of hospitalised Covid patients had fibrotic patterning after recovery from the acute illness," said corresponding author Iain Stewart, an advanced research fellow (Rayne

Alembic gets final USFDA nod for medication to treat bronchoconstriction

Alembic Pharmaceuticals Ltd on Wednesday said it has received final approval from the US health regulator for its generic version of Arformoterol Tartrate inhalation solution indicated for long-term treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease. The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for Arformoterol Tartrate inhalation solution is for strength of 15 mcg (base)/2 mL unit-dose vial, the company said in a statement. The approved ANDA is therapeutically equivalent to the reference-listed drug product (RLD), Brovana inhalation solution, 15 mcg/2 mL, of Sunovion Pharmaceuticals Inc, it added. Arformoterol Tartrate inhalation solution is indicated for long-term, twice daily administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, the company said. This ANDA has ...

How coronavirus changed the way we support people with respiratory disease

With clinical opinion changing so quickly, it's worth reflecting on how and why this has happened - particularly as the scientific evidence to back up this change is lagging behind clinical practice

Nitrate supplements can help in breathing, lung clearance in elderly: Study

Improving the function in the diaphragm, recent research in mice has shown that nitrate can help the muscle involved in coughing and breathing, by enhancing its power

Compound found in cannabis may help avert lung damage in Covid-19: Report

CBD, a non-intoxicating cannabinoid found in the ingredients of cannabis (marijuana), may reduce lung inflammation in Covid-19 patients

'Asthma is absent among top Covid-19 risk factors'

There's been a run on inhalers, and coronavirus patients like the actor Idris Elba have openly worried about their asthma.

New steroid treatment for kids with lung condition

According to researchers, ARDS affects hundreds of thousands of people each year.